CD14 and Brain atrophy: The potential of peripheral (plasma) CD14 to serve as a biomarker for neurological conditions was confirmed by a meta-analysis, which found that elevated plasma soluble CD14 is associated with an increased risk of incident dementia as well as with markers of brain injury and aging, such as brain atrophy and executive function decline [30].